New evidence for the assessment and testing of patients with penicillin allergy

New guidelines published in Clinical & Experimental Allergy will help doctors evaluate and test patients for possible penicillin allergy.

The guideline was developed by the Standards of Care Committee of the British Society of Allergy and Clinical Immunology (BSACI) together with a panel of experts and key stakeholders.

The group’s recommendations include a checklist to identify patients at low risk of allergy and a framework for drug stimulation testing – or penicillin exposure in a controlled environment – to be performed by non-allergists. There are separate recommendations for adults and children in the guideline.

“The intended users are not allergic and have an interest in elucidating the penicillin allergy status of their patients. The guidelines describe appropriate patient selection, risk classification, minimum safety standards, drug stimulus testing, and the degree of control required from allergists or immunologists.” The guideline will be revised 5 years after the date of original publication.


Journal reference:

Savic, L.; et al. (2022) BSACI guide for setting up penicillin allergy label removal services by non-allergists working in a hospital setting. Clinical and experimental sensitivity.

Source link

Related Posts